about
Optimization of liposomal topotecan for use in treating neuroblastoma.ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors.Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers.ABVD chemotherapy with reduced radiation therapy rates in children, adolescents and young adults with all stages of Hodgkin lymphoma.Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits.Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project.Dexmedetomidine and hydromorphone: a novel pain management strategy for the oncology ward setting during anti-GD2 immunotherapy for high-risk neuroblastoma in children.Paroxysmal nocturnal haemoglobinuria phenotype cells and leucocyte subset telomere length in childhood acquired aplastic anaemia.Antidepressant use among survivors of childhood, adolescent, and young adult cancer: letter to the editor response.Low oxygen saturation by pulse oximetry may be associated with a low oxygen affinity hemoglobin variant, hemoglobin Titusville.Nivolumab in the Treatment of Refractory Pediatric Hodgkin Lymphoma.Application of genomics to identify therapeutic targets in recurrent pediatric papillary thyroid carcinoma.Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218Immunosuppressive Therapy Without Hematopoietic Growth Factor Exposure in Pediatric Acquired Aplastic AnemiaTumor Variant Identification That Accounts for the Unique Molecular Landscape of Pediatric MalignanciesPediatric oncology and stem cell transplant patients with healthcare-associated Clostridium difficile infection were already colonized on admissionPhase I dose-finding study for melatonin in pediatric oncology patients with relapsed solid tumorsALK-Positive Lung Adenocarcinoma Arising in an Adolescent Treated for Relapsed NeuroblastomaComparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed CancerIfosfamide, gemcitabine, and vinorelbine is an effective salvage regimen with excellent stem cell mobilization in relapsed or refractory pediatric Hodgkin lymphomaThe Utility of PET/CT in Guiding Radiotherapy Reduction for Children With Hodgkin Lymphoma Treated With ABVD
P50
Q33775276-A24AA8B5-A8FF-4DDB-9CAD-B06F114A3121Q34529577-EF161142-EB18-4CBF-92F9-CE658D50EB17Q36851421-175EEA25-6804-4EF6-A29F-50271B8C1DF8Q40281182-C426DF6E-7B91-4E63-88B3-1825968932F5Q41620161-E2752A10-1EB0-40C8-8A57-AEB0E2DFF8BFQ43732741-27EA17C4-F82B-4990-9F1A-5FD7394FC355Q44237758-17415F5F-571A-4819-B374-87AF6BAB5A64Q44390459-4B62936A-8BAB-41A1-8752-7BA5EB45389CQ46779980-C34032DB-4A2E-4275-8901-F5798EC97118Q47641760-80C2B6EA-3F5B-4EB9-93BA-E2941A8F36ABQ51328423-E4B44F7E-7788-44E1-8068-7C15550E55A5Q55362706-B6DBFF70-B333-4576-9E54-5C60E8B52CADQ58613208-A1D59E61-A450-4FC1-B541-6802D9F80AF9Q59094073-A213C81F-23A3-4862-92B7-62FEEA747AA2Q64296260-82E7D6EF-D5CB-4EE0-8F1C-3D9FC8226086Q91151616-6DD998BE-D55A-4BBC-963A-17CC30EDECEFQ91750352-9EDA0581-1D56-4DCA-8EAD-125356A51486Q92251220-CE6B0CB1-364B-43B2-BE44-1BA71A9C3FA2Q92358462-CD45E833-52DC-42A9-AFEC-DF92F3FDA1A3Q92568419-FC8F239A-8130-4565-A925-CC981AC0EAC7Q93156890-F3C35846-2288-4232-901A-6FFE1128ABE2
P50
description
researcher, ORCID id # 0000-0003-3315-4383
@en
wetenschapper
@nl
name
Rebecca Deyell
@ast
Rebecca Deyell
@en
Rebecca Deyell
@es
Rebecca Deyell
@nl
type
label
Rebecca Deyell
@ast
Rebecca Deyell
@en
Rebecca Deyell
@es
Rebecca Deyell
@nl
prefLabel
Rebecca Deyell
@ast
Rebecca Deyell
@en
Rebecca Deyell
@es
Rebecca Deyell
@nl
P106
P21
P31
P496
0000-0003-3315-4383